by Veronique Ropion | Mar 24, 2026 | Quality & Business Excellence
Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...
by milena henderson | Mar 19, 2026 | GCLP Accreditation Scheme, Quality & Business Excellence
On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...
by milena henderson | Mar 16, 2026 | Quality & Business Excellence
At Pharmalys, Quality is more than just a word – it is our promise. Quality can be defined as the standard of something as measured against other things of a similar kind, or the degree of excellence achieved. In clinical research, Quality ensures that clinical...
by milena henderson | Mar 10, 2026 | Quality & Business Excellence
We would like to extend a sincere thank you to all our clients who took time out of their busy schedules to participate in the 2025 Pharmalys Client Experience Survey. We are truly grateful for the detailed feedback you provided. Your insights are invaluable and play...
by milena henderson | Mar 5, 2026 | Non classé, Quality & Business Excellence
Pharmalys was pleased to participate in the first congress of the Syndicat des Médecins Privés du Sénégal, held over three days from 22 to 24 January at the King Fahd Palace Hotel in Dakar. As part of the symposium “Advocacy for research in the private health sector,”...
by milena henderson | Feb 26, 2026 | Quality & Business Excellence
We are proud to celebrate the winners of our 2025 Awards Ceremony, recognised during our Annual Meeting in December and recently honoured with a symbolic trophy presentation at our Dakar office. In the Awards Ceremony, 34 team members were recognised across three key...
